Trial
NCT00722917
Efficacy and Safety of TAK-379 in Adult Subjects With Type 2 Diabetes Mellitus
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Takeda
Collaborators
—
Condition
Diabetes Mellitus
Intervention
TAK-379
Why stopped
Animal Toxicity Findings
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-06-22